Company News

The European Society of Cardiology (ESC) Has Issued Care Guidelines for Cardio-Oncology & Recognized Fast-SENC (MyoStrain®) As an Alternative Diagnostic Option
For any technology company to be recognized in treatment guidelines before widespread adoption is an extreme honor and a credit to the strong data and principal investigators who have diligently performed MyoStrain® studies...
This is some text inside of a div block.
September 7, 2022
Hyperventilation Strain CMR Imaging in Patients With Acute Chest Pain
MyoStress™, a rapid stress test utilizing breathing maneuvers, has continued to demonstrate excellent accuracy at detecting ischemic coronary artery disease without the need for pharmacologic stress agents or contrast injections in this new publication from University of Heidelberg...
This is some text inside of a div block.
August 9, 2022
MSI Releases New United States Software Version MyoStrain® 5.4
Myocardial Solutions, Inc. (MSI) released a new software version in the United States much like version 5.2.4 for the European Market. The updated software features...
This is some text inside of a div block.
August 1, 2022
Dr. Beatriz Lopez Melgar, Head of the New MyoStrain® Cardiac Prevention Program at Sanitas Healthcare, Addressed the MSI Board To Speak About the Importance of MyoStrain®
Dr. Melgar presented five cases where she demonstrated the clinical value of MyoStrain® over traditional metrics and current standard of care protocols. She evaluated and explained how MyoStrain provides additional information when making treatment decisions. In all five cases...
This is some text inside of a div block.
July 19, 2022
First MyoStrain® Cardio-Oncology Center Opens at La Milagrosa in Partnership with Vithas Group in Madrid
Myocardial Solutions, Inc. (MSI) announced the opening of the first MyoStrain Cardio-Oncology Center in Madrid. The Center represents a partnership between MSI and Vithas Group (Vithas), a chain of Spanish...
This is some text inside of a div block.
June 14, 2022

Get Email Alerts

Subscribe to the newsletter to receive instant email notifications and alerts when news comes MyoStrain® and Myocardial Solutions, Inc.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.